Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1786 1
1787 1
1788 1
1790 1
1792 1
1797 1
1800 2
1804 1
1806 5
1807 2
1808 3
1809 2
1810 2
1811 1
1812 1
1852 1
1862 2
1863 3
1864 3
1865 1
1867 1
1868 1
1869 4
1870 1
1872 3
1873 1
1874 3
1875 2
1876 1
1883 1
1885 4
1886 2
1887 2
1888 2
1889 3
1890 2
1891 4
1892 1
1893 3
1894 3
1895 5
1896 4
1897 8
1898 4
1899 7
1900 4
1901 5
1902 6
1903 4
1904 2
1905 3
1906 3
1907 6
1908 3
1909 5
1910 3
1911 4
1912 5
1913 5
1914 9
1915 3
1916 2
1917 4
1918 1
1919 3
1920 1
1921 2
1922 1
1923 2
1925 1
1928 2
1935 1
1936 1
1937 1
1945 2
1946 2
1947 6
1948 1
1949 3
1950 1
1951 2
1952 5
1953 2
1954 5
1955 9
1957 3
1958 7
1959 5
1960 7
1961 10
1962 7
1963 4
1964 11
1965 28
1966 11
1967 7
1968 16
1969 23
1970 16
1971 19
1972 27
1973 11
1974 24
1975 15
1976 26
1977 22
1978 14
1979 25
1980 27
1981 23
1982 23
1983 24
1984 23
1985 42
1986 34
1987 45
1988 38
1989 41
1990 51
1991 44
1992 37
1993 53
1994 59
1995 54
1996 56
1997 57
1998 53
1999 55
2000 64
2001 69
2002 62
2003 48
2004 78
2005 95
2006 99
2007 123
2008 107
2009 120
2010 100
2011 95
2012 116
2013 138
2014 119
2015 130
2016 119
2017 125
2018 145
2019 151
2020 207
2021 227
2022 172
2023 161
2024 82

Text availability

Article attribute

Article type

Publication date

Search Results

4,055 results

Results by year

Filters applied: . Clear all
Page 1
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
Mellinghoff IK, van den Bent MJ, Blumenthal DT, Touat M, Peters KB, Clarke J, Mendez J, Yust-Katz S, Welsh L, Mason WP, Ducray F, Umemura Y, Nabors B, Holdhoff M, Hottinger AF, Arakawa Y, Sepulveda JM, Wick W, Soffietti R, Perry JR, Giglio P, de la Fuente M, Maher EA, Schoenfeld S, Zhao D, Pandya SS, Steelman L, Hassan I, Wen PY, Cloughesy TF; INDIGO Trial Investigators. Mellinghoff IK, et al. Among authors: clarke j. N Engl J Med. 2023 Aug 17;389(7):589-601. doi: 10.1056/NEJMoa2304194. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272516 Clinical Trial.
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis: A Report of the American College of Cardiology Solution Set Oversight Committee.
Writing Committee; Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, Clarke JO, Dember LM, Frantz JG, Hershberger RE, Maurer MS, Nativi-Nicolau J, Sanchorawala V, Sheikh FH. Writing Committee, et al. Among authors: clarke jo. J Am Coll Cardiol. 2023 Mar 21;81(11):1076-1126. doi: 10.1016/j.jacc.2022.11.022. Epub 2023 Jan 23. J Am Coll Cardiol. 2023. PMID: 36697326 Free article. No abstract available.
Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: a randomized, perioperative phase 1 trial.
Mellinghoff IK, Lu M, Wen PY, Taylor JW, Maher EA, Arrillaga-Romany I, Peters KB, Ellingson BM, Rosenblum MK, Chun S, Le K, Tassinari A, Choe S, Toubouti Y, Schoenfeld S, Pandya SS, Hassan I, Steelman L, Clarke JL, Cloughesy TF. Mellinghoff IK, et al. Among authors: clarke jl. Nat Med. 2023 Mar;29(3):615-622. doi: 10.1038/s41591-022-02141-2. Epub 2023 Feb 23. Nat Med. 2023. PMID: 36823302 Free PMC article. Clinical Trial.
Reflecting on 2022.
Clarke J; PLOS Biology Staff Editors. Clarke J, et al. PLoS Biol. 2022 Dec 16;20(12):e3001957. doi: 10.1371/journal.pbio.3001957. eCollection 2022 Dec. PLoS Biol. 2022. PMID: 36525462 Free PMC article.
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice.
Fontes-Dantas FL, Fernandes GG, Gutman EG, De Lima EV, Antonio LS, Hammerle MB, Mota-Araujo HP, Colodeti LC, Araújo SMB, Froz GM, da Silva TN, Duarte LA, Salvio AL, Pires KL, Leon LAA, Vasconcelos CCF, Romão L, Savio LEB, Silva JL, da Costa R, Clarke JR, Da Poian AT, Alves-Leon SV, Passos GF, Figueiredo CP. Fontes-Dantas FL, et al. Among authors: clarke jr. Cell Rep. 2023 Mar 28;42(3):112189. doi: 10.1016/j.celrep.2023.112189. Epub 2023 Feb 17. Cell Rep. 2023. PMID: 36857178 Free PMC article.
Human naive epiblast cells possess unrestricted lineage potential.
Guo G, Stirparo GG, Strawbridge SE, Spindlow D, Yang J, Clarke J, Dattani A, Yanagida A, Li MA, Myers S, Özel BN, Nichols J, Smith A. Guo G, et al. Among authors: clarke j. Cell Stem Cell. 2021 Jun 3;28(6):1040-1056.e6. doi: 10.1016/j.stem.2021.02.025. Epub 2021 Apr 7. Cell Stem Cell. 2021. PMID: 33831366 Free PMC article.
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial.
Hong DS, Van Tine BA, Biswas S, McAlpine C, Johnson ML, Olszanski AJ, Clarke JM, Araujo D, Blumenschein GR Jr, Kebriaei P, Lin Q, Tipping AJ, Sanderson JP, Wang R, Trivedi T, Annareddy T, Bai J, Rafail S, Sun A, Fernandes L, Navenot JM, Bushman FD, Everett JK, Karadeniz D, Broad R, Isabelle M, Naidoo R, Bath N, Betts G, Wolchinsky Z, Batrakou DG, Van Winkle E, Elefant E, Ghobadi A, Cashen A, Grand'Maison A, McCarthy P, Fracasso PM, Norry E, Williams D, Druta M, Liebner DA, Odunsi K, Butler MO. Hong DS, et al. Among authors: clarke jm. Nat Med. 2023 Jan;29(1):104-114. doi: 10.1038/s41591-022-02128-z. Epub 2023 Jan 9. Nat Med. 2023. PMID: 36624315 Free PMC article. Clinical Trial.
Migratory and anti-fibrotic programmes define the regenerative potential of human cardiac progenitors.
Poch CM, Foo KS, De Angelis MT, Jennbacken K, Santamaria G, Bähr A, Wang QD, Reiter F, Hornaschewitz N, Zawada D, Bozoglu T, My I, Meier A, Dorn T, Hege S, Lehtinen ML, Tsoi YL, Hovdal D, Hyllner J, Schwarz S, Sudhop S, Jurisch V, Sini M, Fellows MD, Cummings M, Clarke J, Baptista R, Eroglu E, Wolf E, Klymiuk N, Lu K, Tomasi R, Dendorfer A, Gaspari M, Parrotta E, Cuda G, Krane M, Sinnecker D, Hoppmann P, Kupatt C, Fritsche-Danielson R, Moretti A, Chien KR, Laugwitz KL. Poch CM, et al. Among authors: clarke j. Nat Cell Biol. 2022 May;24(5):659-671. doi: 10.1038/s41556-022-00899-8. Epub 2022 May 12. Nat Cell Biol. 2022. PMID: 35550611 Free PMC article.
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial.
Mellinghoff IK, Penas-Prado M, Peters KB, Burris HA 3rd, Maher EA, Janku F, Cote GM, de la Fuente MI, Clarke JL, Ellingson BM, Chun S, Young RJ, Liu H, Choe S, Lu M, Le K, Hassan I, Steelman L, Pandya SS, Cloughesy TF, Wen PY. Mellinghoff IK, et al. Among authors: clarke jl. Clin Cancer Res. 2021 Aug 15;27(16):4491-4499. doi: 10.1158/1078-0432.CCR-21-0611. Epub 2021 Jun 2. Clin Cancer Res. 2021. PMID: 34078652 Free PMC article. Clinical Trial.
4,055 results